secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001628280-26-028425
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus Life Sciences Chief of Clinical Operations Jodi Devlin to retire October 1, 2026
--------------------------------------------------------------------------------

- Jodi Devlin notified Company on April 24, 2026 of retirement as Chief of Clinical Operations.
- Retirement effective October 1, 2026; Company expresses gratitude for her contributions.
- Previously announced Dr. Richard Marshall as new Chief Medical Officer effective June 29, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/tlsi-20260424.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-028425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer